As surgical techniques continue to evolve—ranging from coronally advanced flaps to connective tissue grafts—the role of adjunctive therapies, particularly systemic antibiotics, remains a topic of ongoing debate among clinicians and researchers.
The narrative review “Antibiotics in Mucogingival Surgery for Recession Treatment” provides a comprehensive and critical analysis of current evidence regarding the use of antibiotics in these procedures.
While antibiotics are traditionally prescribed to prevent postoperative infections and enhance healing, their routine use in otherwise healthy patients undergoing mucogingival surgery is increasingly being questioned.
This article explores whether antibiotics truly improve clinical outcomes such as root coverage success, tissue stability, and patient-reported comfort, or if their use may be unnecessary in many cases.
Importantly, it also addresses the broader implications of antibiotic overprescription, including the growing global concern of antimicrobial resistance—a key issue in both dentistry and general medicine.
By synthesizing findings from available clinical studies, the review helps clinicians better understand when antibiotic therapy may be justified and when it can be safely avoided.
This evidence-based perspective is essential for promoting responsible prescribing practices while maintaining optimal surgical outcomes.
📖 We invite dentists and specialists worldwide to explore the full article in PDF and deepen their understanding of antibiotic use in mucogingival surgery for gingival recession treatment.
